NASDAQ:PIII - Nasdaq - US7444131053 - Common Stock - Currency: USD
0.2181
+0 (+1.58%)
The current stock price of PIII is 0.2181 USD. In the past month the price increased by 12.25%. In the past year, price decreased by -78.83%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CI | THE CIGNA GROUP | 10.96 | 82.05B | ||
CVS | CVS HEALTH CORP | 12.01 | 81.91B | ||
LH | LABCORP HOLDINGS INC | 17.1 | 20.78B | ||
DGX | QUEST DIAGNOSTICS INC | 19.08 | 19.11B | ||
HIMS | HIMS & HERS HEALTH INC | 150.93 | 14.51B | ||
FMS | FRESENIUS MEDICAL CARE-ADR | 13.65 | 13.46B | ||
BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 157.21 | 12.87B | ||
DVA | DAVITA INC | 15.36 | 11.97B | ||
CHE | CHEMED CORP | 24.01 | 8.24B | ||
CRVL | CORVEL CORP | 27.34 | 5.87B | ||
GH | GUARDANT HEALTH INC | N/A | 5.86B | ||
OPCH | OPTION CARE HEALTH INC | 27.22 | 5.51B |
P3 Health Partners, Inc. is a population health care management company, which engages in the provision of professional support services to doctors and clinicians. The company is headquartered in Chicago, Illinois and currently employs 400 full-time employees. The company went IPO on 2021-02-10. The firm supports primary care providers with value-based care coordination and administrative services that improve patient outcomes and lower costs. Through partnerships with these local providers, it creates an enhanced patient experience by navigating, coordinating, and integrating the patient’s care within the healthcare system. Its technology platform, P3 Technology/Health Hub, enables physicians, care teams, patients and their family members to engage in the care journey. P3 Technology/Health Hub integrates clinical and claims data from more than 250 disparate data points each month from payors, outpatient and inpatient facilities and other ancillary care settings. The company has a network of more than 2,800 affiliated primary care providers across the country. Its local teams of health care professionals manage the care of thousands of patients in 23 counties across five states.
P3 HEALTH PARTNERS INC
2045 W Grand Ave Ste B, Pmb # 82152
Chicago ILLINOIS US
Employees: 400
Company Website: https://ir.p3hp.org/
Investor Relations: https://ir.p3hp.org/
Phone: 13128228897
The current stock price of PIII is 0.2181 USD. The price increased by 1.58% in the last trading session.
The exchange symbol of P3 HEALTH PARTNERS INC is PIII and it is listed on the Nasdaq exchange.
PIII stock is listed on the Nasdaq exchange.
11 analysts have analysed PIII and the average price target is 0.77 USD. This implies a price increase of 250.76% is expected in the next year compared to the current price of 0.2181. Check the P3 HEALTH PARTNERS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
P3 HEALTH PARTNERS INC (PIII) has a market capitalization of 78.26M USD. This makes PIII a Micro Cap stock.
P3 HEALTH PARTNERS INC (PIII) currently has 400 employees.
P3 HEALTH PARTNERS INC (PIII) has a support level at 0.21 and a resistance level at 0.23. Check the full technical report for a detailed analysis of PIII support and resistance levels.
The Revenue of P3 HEALTH PARTNERS INC (PIII) is expected to grow by 23.34% in the next year. Check the estimates tab for more information on the PIII EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
PIII does not pay a dividend.
P3 HEALTH PARTNERS INC (PIII) will report earnings on 2025-03-26, after the market close.
P3 HEALTH PARTNERS INC (PIII) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.76).
The outstanding short interest for P3 HEALTH PARTNERS INC (PIII) is 3.56% of its float. Check the ownership tab for more information on the PIII short interest.
ChartMill assigns a technical rating of 2 / 10 to PIII. When comparing the yearly performance of all stocks, PIII is a bad performer in the overall market: 93.46% of all stocks are doing better.
ChartMill assigns a fundamental rating of 1 / 10 to PIII. PIII may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months PIII reported a non-GAAP Earnings per Share(EPS) of -0.76. The EPS increased by 71.75% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -12.32% | ||
ROE | -85.21% | ||
Debt/Equity | 1.11 |
ChartMill assigns a Buy % Consensus number of 80% to PIII. The Buy consensus is the average rating of analysts ratings from 11 analysts.
For the next year, analysts expect an EPS growth of -1.61% and a revenue growth 23.34% for PIII